PetMed Express Statistics
Total Valuation
PetMed Express has a market cap or net worth of $36.33 million. The enterprise value is -$17.40 million.
Important Dates
The next estimated earnings date is Monday, February 2, 2026, after market close.
| Earnings Date | Feb 2, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PetMed Express has 21.00 million shares outstanding. The number of shares has increased by 0.98% in one year.
| Current Share Class | 21.00M |
| Shares Outstanding | 21.00M |
| Shares Change (YoY) | +0.98% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 7.83% |
| Owned by Institutions (%) | 27.92% |
| Float | 13.63M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.16 |
| Forward PS | n/a |
| PB Ratio | 0.42 |
| P/TBV Ratio | 0.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 7.70 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.26 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6.90% and return on invested capital (ROIC) is -5.62%.
| Return on Equity (ROE) | -6.90% |
| Return on Assets (ROA) | -3.25% |
| Return on Invested Capital (ROIC) | -5.62% |
| Return on Capital Employed (ROCE) | -9.65% |
| Revenue Per Employee | $1.31M |
| Profits Per Employee | -$36,249 |
| Employee Count | 173 |
| Asset Turnover | 1.42 |
| Inventory Turnover | 7.05 |
Taxes
In the past 12 months, PetMed Express has paid $5.68 million in taxes.
| Income Tax | 5.68M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.13% in the last 52 weeks. The beta is 0.77, so PetMed Express's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -65.13% |
| 50-Day Moving Average | 2.34 |
| 200-Day Moving Average | 3.21 |
| Relative Strength Index (RSI) | 35.29 |
| Average Volume (20 Days) | 219,836 |
Short Selling Information
The latest short interest is 1.57 million, so 7.48% of the outstanding shares have been sold short.
| Short Interest | 1.57M |
| Short Previous Month | 1.66M |
| Short % of Shares Out | 7.48% |
| Short % of Float | 11.53% |
| Short Ratio (days to cover) | 9.75 |
Income Statement
In the last 12 months, PetMed Express had revenue of $226.97 million and -$6.27 million in losses. Loss per share was -$0.30.
| Revenue | 226.97M |
| Gross Profit | 69.14M |
| Operating Income | -8.29M |
| Pretax Income | -587,000 |
| Net Income | -6.27M |
| EBITDA | -1.25M |
| EBIT | -8.29M |
| Loss Per Share | -$0.30 |
Full Income StatementBalance Sheet
The company has $54.72 million in cash and $996,000 in debt, giving a net cash position of $53.72 million or $2.56 per share.
| Cash & Cash Equivalents | 54.72M |
| Total Debt | 996,000 |
| Net Cash | 53.72M |
| Net Cash Per Share | $2.56 |
| Equity (Book Value) | 85.13M |
| Book Value Per Share | 4.12 |
| Working Capital | 16.10M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.72 million and capital expenditures -$5.11 million, giving a free cash flow of -$395,000.
| Operating Cash Flow | 4.72M |
| Capital Expenditures | -5.11M |
| Free Cash Flow | -395,000 |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 30.46%, with operating and profit margins of -3.65% and -2.76%.
| Gross Margin | 30.46% |
| Operating Margin | -3.65% |
| Pretax Margin | -0.26% |
| Profit Margin | -2.76% |
| EBITDA Margin | -0.55% |
| EBIT Margin | -3.65% |
| FCF Margin | n/a |
Dividends & Yields
PetMed Express does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.98% |
| Shareholder Yield | -0.98% |
| Earnings Yield | -17.26% |
| FCF Yield | -1.09% |
Dividend DetailsAnalyst Forecast
The average price target for PetMed Express is $3.20, which is 83.91% higher than the current price. The consensus rating is "Sell".
| Price Target | $3.20 |
| Price Target Difference | 83.91% |
| Analyst Consensus | Sell |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on March 4, 1999. It was a forward split with a ratio of 3:1.
| Last Split Date | Mar 4, 1999 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
PetMed Express has an Altman Z-Score of 2.92 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.92 |
| Piotroski F-Score | 2 |
